Difference between revisions of "Part:BBa K4361303"

 
 
(7 intermediate revisions by 2 users not shown)
Line 3: Line 3:
 
<partinfo>BBa_K4361303 short</partinfo>
 
<partinfo>BBa_K4361303 short</partinfo>
  
−
A mutant of the BlcR protein, created through site-directed mutagenesis with primers R4 ([[Part:BBa_K4361204]]) and F4.2 G41A (<b>TBD</b>). For this mutant, the glycine in position 41 has been changed to alanine by mutating the GGC codon to GCG.
+
A mutant of the BlcR protein, created through site-directed mutagenesis with primers R7 ([[Part:BBa_K4361210]]) and F7.1 S61V ([[Part:BBa_K4361211]]). For this mutant, the serine in position 61 has been changed to valine by mutating the AGT codon to GTG.
  
 
This mutant also contains the following nucleotide mutations outside of the targeted site:
 
This mutant also contains the following nucleotide mutations outside of the targeted site:
 
<ul>
 
<ul>
  
−
<li>.</li>
+
<li>C 705 > T, silent mutation</li>
 
</ul>
 
</ul>
  
Line 15: Line 15:
  
 
<!-- -->
 
<!-- -->
−
<span class='h3bb'>Sequence and Features</span>
+
<span class='h3bb'><h3>Sequence and Features</h3></span>
 
<partinfo>BBa_K4361303 SequenceAndFeatures</partinfo>
 
<partinfo>BBa_K4361303 SequenceAndFeatures</partinfo>
  
 +
<html>
 +
<h3>Usage and Biology</h3>
 +
The set of BlcR mutants (</html>[[Part:BBa_K4361300]] through [[Part:BBa_K4361319]]<html>) were expressed in a PURE system in the presence of GreenLys (fluorescent Cy2-labeled lysine). Samples were then run on an SDS PAGE gel (<b>Figure 1.</b>) to determine whether or not the protein was produced. For this mutant (<u>lane 4</u>), a protein band corresponding to the BlcR monomer is visible. Concluding that the production in an E. coli cell-free system was successful for this mutant.
 +
 +
<figure>
 +
<a href="https://static.igem.wiki/teams/4361/wiki/results/figure-7-pure/figure-7-pure-4.png"><img src="https://static.igem.wiki/teams/4361/wiki/results/figure-7-pure/figure-7-pure-4.png" style="width:600px;margin-left:125px"></a>
 +
<figcaption> <b>Figure 1.</b> SDS PAGE showing the translation products of 20 different plasmids coding for BlcR mutants. PURE reaction solution was supplemented with GreenLys and the synthesized proteins were imaged with Typhoon using a 488-nm laser. C: negative control with no plasmid. WT: positive control with expressed wildtype BlcR. 4: S61V mutant.</figcaption>
 +
</figure>
 +
 +
 +
</html>
  
 
<!-- Uncomment this to enable Functional Parameter display  
 
<!-- Uncomment this to enable Functional Parameter display  

Latest revision as of 18:16, 13 October 2022


BlcR S61V

A mutant of the BlcR protein, created through site-directed mutagenesis with primers R7 (Part:BBa_K4361210) and F7.1 S61V (Part:BBa_K4361211). For this mutant, the serine in position 61 has been changed to valine by mutating the AGT codon to GTG.

This mutant also contains the following nucleotide mutations outside of the targeted site:

  • C 705 > T, silent mutation

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    INCOMPATIBLE WITH RFC[12]
    Illegal NheI site found at 694
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal NgoMIV site found at 78
  • 1000
    INCOMPATIBLE WITH RFC[1000]
    Illegal SapI.rc site found at 589

Usage and Biology

The set of BlcR mutants (Part:BBa_K4361300 through Part:BBa_K4361319) were expressed in a PURE system in the presence of GreenLys (fluorescent Cy2-labeled lysine). Samples were then run on an SDS PAGE gel (Figure 1.) to determine whether or not the protein was produced. For this mutant (lane 4), a protein band corresponding to the BlcR monomer is visible. Concluding that the production in an E. coli cell-free system was successful for this mutant.
Figure 1. SDS PAGE showing the translation products of 20 different plasmids coding for BlcR mutants. PURE reaction solution was supplemented with GreenLys and the synthesized proteins were imaged with Typhoon using a 488-nm laser. C: negative control with no plasmid. WT: positive control with expressed wildtype BlcR. 4: S61V mutant.